Recommended Readings

The Sustainability Problem 

ECON Centre for Economic Analysis. 2006. Developing benchmarks for financing immunization . Report 25/03 Commissioned by The Bill and Melinda Gates Foundation.

Kaddar M, Lydon P, Levine R. 2004. Financial challenges of immunization: a look at GAVI. Bulletin of the World Health Organization. Sep;82(9):697-702.

Lydon P. 2006. Immunization Financing Analysis. A look across 50 GAVI countries . Unpublished paper. Dept. of Immunizations, Vaccines and Biologicals. World Health Organization.

Peny JM, Gleizes O, Covilard JP. 2005. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective. Vaccine. 2005 Aug 31;23(37):4610-8.

Scheiber, G, C Baeza, D Kress, Maier M. 2006. Financing Health Systems in the 21st Century. Chapter 12 in: Jamison et al. (eds): Disease Control Priorities in Developing Countries. Second Edition. Washington, DC: The World Bank.

World Health Organization. 2006. The cost of immunization programmes in the next 10 years.

GAVI Grant Mechanics

Centers for Disease Control and Prevention (CDC). 2006. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015 . MMWR. May 12;55(18):511-5.

GAVI 2006. Country progress reports and recommendations.

World Health Organization. 2006. WHO-UNICEF guidelines for preparing a multi-year plan (cMYP). Expanded Programme on Immunization of the Department of Immunization, Vaccines and Biologicals. Document WHO/IVB/05.20.

World Health Organization and UNICEF. 2005. Global Immunization Vision and Strategy 2006-2015. Dept. of Immunizations, Vaccines and Biologicals, World Health Organization.

Civil Society

Agerskov, Anders Hjorth. 2005. Global Public Goods and Development – A Guide for Policy Makers. Seminar No. 6. World Bank Seminar Series at Kobe and Hiroshima Universities. Global Development Challenges Facing Humanity.

GAVI. 2007. Enhancing civil society participation in GAVI Alliance governance and programme implementation 2007-2008 . Background Paper Doc. A2, 19^th GAVI Alliance Board Meeting, 29 November 2006 (prepared by Allan Bass).

The Economics of Immunization

Bloom D, Canning D, Weston M. 2005.  The value of vaccination .  World Economics, 6(3), 15-40.

Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey, NA. 2006. Vaccine-Preventable Diseases. Chapter 20 in: Jamison et al. (eds): Disease Control Priorities in Developing Countries. Second Edition. Washington, DC: The World Bank.

Fox-Rushby JA, Kaddar M, Levine R, Brenzel L. 2004. The economics of vaccination in low- and middle-income countries . Bulletin of the World Health Organization, 82:640.

Kaul I, Faust M. 2001. Global public goods and health: taking the agenda forward . Bulletin of the World Health Organization, 2001, 79: 869–874.

Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P. 2004. Economic analysis of the 1996–1997 mass measles immunization campaigns in South Africa. Vaccine, 22(25–26): 3419–26

World Health Organization. 2003. Multi-country evaluation of IMCI effectiveness, cost and impact (MCE). Progress report May 2002–April 2003. Geneva, World Health Organization, (WHO/FCH/CAH/03.5). Available at: http://www.who.int/imci-mce/

 
Parliaments

Mataure M. 2003. Parliamentary Functions and Reforms and their application in promoting Health Equity in Southern Africa . Unpublished paper. Southern African Regional Network for Equity in Health (EQUINET).

General

Khan MM, Ehreth J. 2003. Costs and benefits of polio eradication: a long-run global perspective. Vaccine, 21(7-8):702-5.

Matthews Z, Diamond I. 1999. The Expanded Programme on Immunisation: mortality consequences and demographic impact in developing countries. Genus, 55: 73–100.

Pigman, H. Conquering Polio. 2005.  Evanston, IL: The Rotary Foundation.

Thompson KM, Radboud J, Tebbens D. 2007. Eradication versus control for poliomyelitis: an economic analysis. Lancet, 369(9570):1363-1371.

World Health Organization. 2006. WHO vaccine-preventable diseases: monitoring system 2006 global summary .  (WHO/IVB/2006). Geneva: Immunization, Vaccines and Biologicals.